MITOLAB
MitoLab is a biotechnology company building a scalable platform for mitochondrial genome engineering. It creates and sells products for use in non-clinical scientific research scenarios. The company’s products are designed to be used in non-clinical research projects assessing the utility of chemical compounds for mitochondrial medicine. Their customers range from multinational companies to individuals specializing in mitochondrial, metabolic, and anti-aging research. Founded by Fahim Farzadfard and Louis J. Kang in 2020 and is headquartered in Allston, Massachusetts, USA.
MITOLAB
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Allston, Massachusetts, United States
Country:
United States
Website Url:
http://www.marchtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Cloudflare JS
Similar Organizations
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Current Employees Featured
Founder
Investors List
The E14 Fund
The E14 Fund investment in Venture Round - MitoLab
